Puma Biotechnology | Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Amgen USD 539M 1000K 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Daiichi Sankyo JPY 1.85B 9K 2025-12
Esperion Therapeutics USD 112K 11K 2023-09
Exelixis USD 268.1M 2.03M 2025-09
Gilead Sciences USD 1.24B 0 2025-09
Glaxosmithkline GBP 4.03B 2.68B 2025-09
Incyte USD 196.13M 2.01M 2025-09
MacroGenics USD 63.26M 62.63M 2025-09
Moderna USD 391M 2M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 79.93M 554K 2025-09
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Takeda JPY 1.58B 2K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


Puma Biotechnology Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.